Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 2
1996 3
1997 3
1998 4
2000 4
2001 4
2002 4
2003 5
2004 4
2005 3
2006 2
2007 2
2008 1
2010 2
2011 3
2012 1
2013 4
2014 2
2015 2
2016 3
2018 2
2020 2
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

62 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators. Zeiser R, et al. N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122. N Engl J Med. 2021. PMID: 34260836 Clinical Trial.
Epigenetic regulation of T cell lineages in skin and blood following hematopoietic stem cell transplantation.
Pandey RV, Strobl J, Redl A, Unterluggauer L, Gail L, Kleissl L, Müller S, Atzmüller D, Fife-Gernedl V, Krausgruber T, Knaus H, Mitterbauer M, Wohlfarth P, Rabitsch W, Bock C, Stary G. Pandey RV, et al. Among authors: mitterbauer m. Clin Immunol. 2023 Mar;248:109245. doi: 10.1016/j.clim.2023.109245. Epub 2023 Jan 23. Clin Immunol. 2023. PMID: 36702179 Free article.
Anti-Apoptotic Molecule BCL2 Is a Therapeutic Target in Steroid-Refractory Graft-Versus-Host Disease.
Strobl J, Pandey RV, Krausgruber T, Kleissl L, Reininger B, Herac M, Bayer N, Krall C, Wohlfarth P, Mitterbauer M, Kalhs P, Rabitsch W, Bock C, Hopfinger G, Stary G. Strobl J, et al. Among authors: mitterbauer m. J Invest Dermatol. 2020 Nov;140(11):2188-2198. doi: 10.1016/j.jid.2020.02.029. Epub 2020 Apr 2. J Invest Dermatol. 2020. PMID: 32247860 Free article.
Cytokine Release Syndrome during Antithymocyte Globulin/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading Criteria.
Knaus HA, Rottner T, Baumann CK, Cserna J, Mitterbauer M, Schulenburg A, Rabitsch W, Wohlfarth P. Knaus HA, et al. Among authors: mitterbauer m. Transplant Cell Ther. 2022 May;28(5):260.e1-260.e9. doi: 10.1016/j.jtct.2022.02.016. Epub 2022 Feb 22. Transplant Cell Ther. 2022. PMID: 35217212 Free article.
Long-term skin-resident memory T cells proliferate in situ and are involved in human graft-versus-host disease.
Strobl J, Pandey RV, Krausgruber T, Bayer N, Kleissl L, Reininger B, Vieyra-Garcia P, Wolf P, Jentus MM, Mitterbauer M, Wohlfarth P, Rabitsch W, Stingl G, Bock C, Stary G. Strobl J, et al. Among authors: mitterbauer m. Sci Transl Med. 2020 Nov 18;12(570):eabb7028. doi: 10.1126/scitranslmed.abb7028. Sci Transl Med. 2020. PMID: 33208504 Free PMC article.
Emergency Department Utilization Following Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Center Retrospective Longitudinal Analysis of 557 Patients.
Cserna J, Baumann CK, Lobmeyr E, Grafeneder J, Ettl F, Eibensteiner F, Rabitsch W, Mitterbauer M, Knaus HA, Wohlfarth P. Cserna J, et al. Among authors: mitterbauer m. Transplant Cell Ther. 2023 May;29(5):321.e1-321.e9. doi: 10.1016/j.jtct.2023.02.018. Epub 2023 Feb 24. Transplant Cell Ther. 2023. PMID: 36842484 Free article.
62 results